BOEHRINGER INGELHEIM PHARMACEUTICALS | Boehringer Ingelheim | aviation safety violation | 2014 | FAA | $15,000 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingleheim | Boehringer Ingelheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000 |
Boehringer Ingelheim Animal Health USA Inc. | Boehringer Ingelheim | employment discrimination | 2020 | OFCCP | $379,089 |
Boehringer Ingelheim International | Boehringer Ingelheim | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Biogen Idec, Inc. | Biogen | wage and hour violation | 2009 | WHD | $49,600 |
Biogen Idec Inc. | Biogen | wage and hour violation | 2005 | WHD | $6,934 |
Biogen Idec Inc. | Biogen | consumer protection violation | 2007 | VT-AG | $10,000 |
Biogen, Inc. | Biogen | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
Biogen Inc. | Biogen | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |
Biogen Inc. | Biogen | benefit plan administrator violation | 2024 | private lawsuit-federal | $9,750,000 |
BIOGEN IDEC, INC. | Biogen | workplace safety or health violation | 2014 | OSHA | $7,500 |
Biocryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | hazardous waste violation | 2014 | AL-ENV | $11,000 |
ISTA Pharmaceuticals, Inc. | Bausch Health | False Claims Act and related | 2013 | DOJ_CIVIL | $33,500,000 |
Medicis Pharmaceutical Corporation | Bausch Health | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $9,800,000 |
ICN Pharmaceuticals, Inc | Bausch Health | economic sanction violation | 2004 | OFAC | $5,500 |
Biovail Corporation | Bausch Health | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | Bausch Health | benefit plan administrator violation | 2016 | EBSA | $10,001 |
BIOVAIL AMERICAS CORP. | Bausch Health | benefit plan administrator violation | 2012 | EBSA | $10,001 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | USAO | $54,000,000 |
Biovail Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2009 | USAO | $24,647,876 |
ICN Pharmaceuticals, Inc. | Bausch Health | fraud | 2001 | USAO | $5,600,000 |
Medicis Pharmaceutical | Bausch Health | employment discrimination | 2016 | private lawsuit-federal | $7,150,000 |
Bausch & Lomb | Bausch Health | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
Biovail | Bausch Health | False Claims Act and related | 2013 | LA-AG | $200,000 |
ISTA Pharmaceuticals, Inc. | Bausch Health | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $390,253 |
Medicis Pharmaceutical Corporation | Bausch Health | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | investor protection violation | 2017 | MULTI-AG | $145,000,000 |
Valeant Pharmaceuticals, Inc. | Bausch Health | insurance violation | 2018 | CA-INS | $1,875,000 |
Bausch Health | Bausch Health | accounting fraud or deficiencies | 2020 | SEC | $45,000,000 |
Bausch & Lomb Inc. | Bausch Health | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $10,000,000 |
Bausch Health Companies Inc. | Bausch Health | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $300,000,000 |
Medicis Pharmaceutical Corp. | Bausch Health | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $23,000,000 |
Medicis Pharmaceutical Corp. | Bausch Health | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $35,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $23,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $37,500,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
BAUSCH AND LOMB PHARMACEUTICALS, INC. | Bausch Health | workplace safety or health violation | 2000 | OSHA | $7,000 |
AstraZeneca LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $7,900,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
AstraZeneca PLC | AstraZeneca | kickbacks and bribery | 2016 | SEC | $5,522,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2011 | OFCCP | $250,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2008 | private lawsuit-state | $350,000 |
Alexion Pharmaceuticals Inc. | AstraZeneca | False Claims Act and related | 2019 | DOJ_CIVIL | $13,000,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2004 | FL-AG | $807,826 |
AstraZeneca | AstraZeneca | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
AstraZeneca | AstraZeneca | consumer protection violation | 2010 | KY-AG | $5,391,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2018 | TX-AG | $110,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | $68,500,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Alexion Pharmaceuticals Inc. | AstraZeneca | Foreign Corrupt Practices Act | 2020 | SEC | $21,000,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2021 | OFCCP | $560,000 |
AstraZeneca | AstraZeneca | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $198,000,000 |
AstraZeneca | AstraZeneca | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
ALEXION PHARMACEUTICALS, INC. | AstraZeneca | workplace safety or health violation | 2012 | OSHA | $8,213 |
MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | environmental violation | 2005 | EPA | $21,125 |
ASTRAZENECA PLP | AstraZeneca | environmental violation | 2021 | EPA | $18,960 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $67,000,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | DOJ_CIVIL | $7,300,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2019 | DOJ_CIVIL | $100,000,000 |
Astellas | Astellas Pharma | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,100,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Astellas Pharma US, Inc. | Astellas Pharma | campaign finance violation | 2022 | FEC | $7,500 |
Astellas Pharma US, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $98,000,000 |
Astellas Pharma US, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $13,250,000 |
Fujisawa Healthcare, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Apotex | Apotex Corp. | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Apotex Corp. | Apotex Corp. | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
Apotex Corporation | Apotex Corp. | False Claims Act and related | 2021 | DOJ_CIVIL | $49,000,000 |
ANIKA THERAPEUTICS INC | Anika Therapeutics | environmental violation | 2003 | MA-ENV | $15,500 |
ANIKA THERAPEUTICS INC. | Anika Therapeutics | workplace safety or health violation | 2013 | OSHA | $5,800 |
Amyris, Inc. | Amyris | investor protection violation | 2021 | SEC | $300,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | drug or medical equipment safety violation | 2017 | DOJ_CIVIL | $35,000,000 |
Aegerion Pharmaceuticals | Amryt Pharma | investor protection violation | 2017 | SEC | $4,100,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
Amphastar Pharmaceuticals | Amphastar Pharmaceuticals | wage and hour violation | 2011 | CA-LCO | $25,000 |
Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | MA-AG | $325,000 |